Research programme: HIV DNA vaccines - Inovio/IAVI

Drug Profile

Research programme: HIV DNA vaccines - Inovio/IAVI

Alternative Names: HIV DNA vaccines - Inovio/IAVI

Latest Information Update: 15 Oct 2012

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Genetronics Inc
  • Developer Genetronics Inc; International AIDS Vaccine Initiative
  • Class AIDS vaccines; DNA vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported HIV infections

Most Recent Events

  • 15 Oct 2012 No development reported - Preclinical for HIV infections in USA (Intradermal)
  • 14 May 2010 Inovio Biomedical is now called Inovio Pharmaceuticals
  • 31 Mar 2007 Preclinical trials in HIV infections in USA (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top